Furthermore, we appreciated a significant positive correlation between ZNF224 expression levels and some molecular markers of CLL proliferation and aggressiveness in B lymphocytes from a small cohort of 22 CLL patients we analyzed (Supplementary Figure.S4). Here, ZNF224 is linked to B-cell chronic lymphocytic leukemia.